The ASX/IMU youtube "Holy Grail of Cancer" interview with LC is,...

The ASX/IMU youtube "Holy Grail of Cancer" interview with LC is, as many have observed ,the best interview LC has done in quite some time.
Its understandable for anyone without knowledge of immuno oncology, its clear what differentiates IMU from other Biotech companies.
Its also clear what the 'scope" of the IMU platform will be, and the time lines to achieve this.

What is also clear is that LC and IMU want to develop a multimodal, individualised oncology treatment platform which has efficacy, minimal side effects across an array of multiple solid tumours which can be deployed at any stage of cancer diagnosis, irrespective of treatment outcomes to date?.

It is also clear to me that once the domino's of clinical studies in advanced solid tumours begin to fall, there will be an avalanche of interest across the globe from patients, big pharma, and the plebiscite.

Well worth watching!.

IMHO

K